News Digest / Ticker: NVAX

Ticker: NVAX

08:03am, Wednesday, Aug 06, 2025

Novavax Faces Revenue Decline Amid COVID-19 Vaccine Approval and Financial Restructuring Efforts

Company Overview: Novavax, Inc. (NASDAQ: NVAX) is a biotechnology company specializing in innovative vaccine development. With a focus on global health challenges, Novavax aims to leverage its proprietary technology platforms to advance vaccines for various infectious diseases. Recent Development...

08:00am, Thursday, May 08, 2025

Novavax Reports Major Revenue Surge in Q1 2025 Despite Cash Burn Concerns and Legal Challenges

08:40am, Friday, May 10, 2024

Novavax Shares Skyrocket Following $1.2 Billion Sanofi Licensing Deal

08:17am, Friday, May 10, 2024

Key Insights Before Friday's Stock Market Opening Bell